Autoimmune gestational diabetes mellitus: A distinct clinical entity?

Dídac Mauricio, Alberto De Leiva

Producció científica: Contribució a una revistaArticle de revisióRecercaAvaluat per experts

18 Cites (Scopus)


This review gives an update of the present knowledge on what is defined here as autoimmune gestational diabetes mellitus (GDM). Autoimmune phenomena associated with type 1 diabetes mellitus (DM) can be detected in a subgroup of women with GDM. Islet autoantibodies are present in sera from women with GDM with variable frequency. Distinct phenotypic and genotypic features may be recognised in this subset of women with GDM, which are representative of a distinct clinical entity. Furthermore, these women are at increased risk of developing type 1 DM after pregnancy. However, the eventual progression of the autoimmune destruction of beta-cells in these subjects may follow different time-course patterns thus leading to variable forms of presentation of autoimmune DM. As a high-risk group for type 1 diabetes, women with previous autoimmune GDM may be candidates for potential immune intervention strategies. Copyright © 2001 John Wiley & Sons, Ltd.
Idioma originalEnglish
Pàgines (de-a)422-428
RevistaDiabetes/Metabolism Research and Reviews
Estat de la publicacióPublicada - 1 de des. 2001


Navegar pels temes de recerca de 'Autoimmune gestational diabetes mellitus: A distinct clinical entity?'. Junts formen un fingerprint únic.

Com citar-ho